Treatment of Hypertension in Primary Care in Spain

Non-interventional,observational and retrospective study assessing the therapeutic and diagnostic attitude followed in primary care for a hypertensive patient depending on his degree of blood pressure control.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, A Coruña, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of primary hypertension and/or treated for hypertension for one year or more
Clinical data of blood pressure measures for the last 12+/- 2 months before inclusion.

Exclusion criteria

Secondary Hypertension
Physical or psychological impairment for the understanding of the information to be given to the patient

Treatment and study plan

Primary outcomes

Therapeutic and diagnostic attitude followed in primary care for a hypertensive patient depending on his degree of blood pressure control.

Time frame: 1 Year

Secondary outcomes

Variation in the Percentage of patients with blood pressure controlled and not controlled during a year of follow-up.

Time frame: 1 Year
Clinical profile and cardiovascular risk.

Time frame: 1 Year

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: TAPAS

Important dates

Study start: 2009
Study completion: 2009
First posted: Mar 25, 2009
Registry last updated: Jul 13, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed